A Placebo-Controlled, Double-blind, Randomized Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants
Latest Information Update: 30 May 2024
At a glance
- Drugs Alprazolam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors UCB Biopharma
- 18 Apr 2024 Results of Pharmacokinetics of Alprazolam , presented at the 76th Annual Meeting of the American Academy of Neurology 2024
- 04 May 2021 Status changed from active, no longer recruiting to completed.
- 29 Apr 2021 Status changed from recruiting to active, no longer recruiting.